Curium, a global leader in nuclear medicine, has completed its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a nuclear medicine manufacturer based in Istanbul, Turkey. The deal enhances Curium’s capabilities in Lutetium-177 (Lu-177) production to support its pipeline of radiopharmaceutical drug candidates for
EnWave Corporation has entered into a master service agreement with BioTechnique, a U.S.-based pharmaceutical contract manufacturing organisation (CDMO). The agreement sets the framework for BioTechnique to assess EnWave’s Radiant Energy Vacuum (REV) dehydration technology as a potential alternative to traditional lyophilization
HAS Healthcare Advanced Synthesis SA (HAS) has announced its acquisition of Cerbios-Pharma SA (Cerbios), a Switzerland-based manufacturer of chemical and biological active pharmaceutical ingredients (APIs). The transaction aims to enhance HAS’s capabilities in high-potency APIs and antibody-drug conjugates (ADCs), further solidifying its
ProBioGen has announced the appointment of Dr. Alfred Merz, PhD, as its new Chief Executive Officer, effective 1 April 2025. Dr. Merz previously served as the company’s Chief Operating Officer and interim CEO. Dr. Merz joined ProBioGen in 2024 from Bayer
“Digital transformation is not about technology deployment. It’s about a new way of doing business that allows you to make jumps which were not possible before, like reducing launch time from 70 weeks to 7 weeks.” – Dr. Franziskus Kath
Zhejiang Langhua Pharmaceutical Co., Ltd. (“Langhua Pharmaceutical”), a wholly owned subsidiary of Viva Biotech Holdings, has passed its fourth on-site Current Good Manufacturing Practices (cGMP) inspection by the U.S. Food and Drug Administration (FDA). Following the inspection, the company received an
Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on inflammation and immunology (I&I) biological products and contract manufacturing, has signed a binding option agreement to acquire Italian biotech firm Pincell srl. The agreement aligns with Scinai’s strategy to advance novel therapies
CordenPharma has been chosen as a Supplier Partner in the Pharmaceutical Supply Chain Initiative (PSCI), joining the programme’s second cohort in March 2025. The selection follows the company’s successful fulfilment of PSCI’s supplier partnership requirements. PSCI is a non-profit association that unites pharmaceutical and healthcare
“Cell and gene therapy is in a winter period. We just need to hold our breath and adapt ourselves to the weather,” observed Miguel Forte, President of ISCT & CEO of Kiji Therapeutics. Miguel Forte chaired the Advanced Therapies UK
SHL Medical, a global provider of advanced drug delivery systems, has announced a strategic partnership with Kindeva Drug Delivery, a contract development and manufacturing organisation (CDMO), to enhance services for the Molly autoinjector platform. The agreement will establish fill-finish and pre-validated
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
